Yeh Chun-Nan

22PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingMolecular targetsCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 13, 2026
High Expression of SSEA3 and Globo H Predicts Poor Outcomes in Resected Extrahepatic Cholangiocarcinoma: A Single-Center Retrospective Cohort Study.

|Apr 12, 2026
Hand-foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor-tyrosine kinase inhibitor treatment.

I-Hsin Huang, Po-Chien Wu, Chun-Nan Yeh

|Feb 07, 2026
Ataxia-telangiectasia mutated kinase inhibition overcomes gemcitabine resistance in intrahepatic cholangiocarcinoma via DNA ligase I-dependent repair vulnerability.

Sheng-Hsuan Lin, Yi-Ru Pan, Tsai-Hsien Hung

|Nov 22, 2025
PufA drives cholangiocarcinoma progression via NFκB signaling activation: a novel therapeutic target.

Chiao-Ping Chen, Tsai-Hsien Hung, Yenlin Huang

|Dec 06, 2023
PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions.

Yi-Ru Pan, Joseph Chieh-Yu Lai, Wen-Kuan Huang

|Jun 28, 2023
Clinical Benefits of Laparoscopic Adhesiolysis during Peritoneal Dialysis Catheter Insertion: A Single-Center Experience.

Hao-Wei Kou, Chun-Nan Yeh, Chun-Yi Tsai

Pageof 4

Frequent Collaborators

8 joint publications

Shang-Yu Wang

5 joint publications

Chiao-En Wu

4 joint publications

Yi-Ru Pan

3 joint publications

Hao-Wei Kou